SCHEMBL4840255

SCHEMBL4840255

COc1ccc(OC)c(C(=O)c2ccc(OC)cc2C(=O)O)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.69
MAPT P10636 2/20 0.68
HTT P42858 2/20 0.68
NPSR1 Q6W5P4 1/20 0.68
POLB P06746 3/20 0.59
LMNA P02545 3/20 0.57
HPGD P15428 3/20 0.57
TSHR P16473 1/20 0.57
HSD17B10 Q99714 1/20 0.57
KDM4E B2RXH2 3/20 0.56
RAB9A P51151 2/20 0.55
NPC1 O15118 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.53
CDC25B P30305 1/20 0.53
CYP2C9 P11712 1/20 0.52
RXFP1 Q9HBX9 1/20 0.52
ABCG2 Q9UNQ0 1/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
AKR1C3 P42330 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5307872 0.91 NPC1 (0.63) ALDH1A1MAPTHTTNPSR1POLB
SCHEMBL4841826 0.90 NPC1 (0.66) ALDH1A1MAPTHTTNPSR1POLB
SCHEMBL12228747 0.89 MAPT (0.82) ALDH1A1MAPTHTTNPSR1POLB
SCHEMBL4840093 0.89 AKR1C3 (0.58) ALDH1A1MAPTHTTNPSR1POLB
SCHEMBL503802 0.88 POLB (0.70) ALDH1A1MAPTHTTNPSR1POLB
SCHEMBL9185042 0.86 POLB (0.68) ALDH1A1MAPTHTTNPSR1POLB
SCHEMBL27939607 0.85 CDC25B (0.66) ALDH1A1HTTPOLBLMNAHPGD
SCHEMBL11395586 0.84 ALDH1A1 (0.62) ALDH1A1MAPTHTTNPSR1POLB
SCHEMBL4843870 0.84 ALDH1A1 (0.67) ALDH1A1MAPTHTTNPSR1POLB
SCHEMBL383820 0.84 ALDH1A1 (0.66) ALDH1A1POLBLMNAHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423030-B2 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof SANOFI-AVENTIS (FR) 2008-09-09 US disclosed
US-20070099895-A1 1-AMINO-PHTHALAZINE DERIVATIVES, THE PREPARATION AND THE THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2007-05-03 US disclosed
CN-1953972-A 1-amino-phthalazine derivatives, their preparation and their therapeutic use SANOFI AVENTIS (FR) 2007-04-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099895-A1 1-AMINO-PHTHALAZINE DERIVATIVES, THE PREPARATION AND THE THERAPEUTIC USE THEREOF CYP11B2, CYP11B1, GOT2 ALDH1A1 86/4885MAPT 459/4885HTT 743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.